Marla J Keller Selected Research

Anti-Infective Agents (Microbicides)

11/2016	In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel.
3/2011	Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
8/2009	Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety.
3/2009	Understanding basic mechanisms and optimizing assays to evaluate the efficacy of vaginal microbicides.
1/2009	Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.
7/2008	Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model.
7/2007	Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections.
5/2007	A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
2/2007	PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
11/2006	Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marla J Keller Research Topics

Disease

13	Infections 11/2016 - 06/2004
6	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2012 - 06/2004
6	Herpes Genitalis (Genital Herpes) 01/2009 - 04/2005
4	COVID-19 01/2022 - 08/2020
3	Inflammation (Inflammations) 01/2019 - 05/2007
3	Herpes Simplex 02/2010 - 01/2006
1	Bacterial Vaginosis 12/2021
1	Abdominal Pain (Pain, Abdominal) 01/2019
1	Ulcer 01/2019
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019
1	Acute Cholecystitis 01/2019
1	Nausea 01/2019
1	Coinfection 01/2017
1	Malaria 09/2014
1	Falciparum Malaria (Plasmodium falciparum Malaria) 09/2014
1	Squamous Intraepithelial Lesions 07/2012
1	Neoplasms (Cancer) 07/2012
1	Uterine Cervical Dysplasia 07/2012
1	Peripheral Arterial Disease 03/2010
1	Acute Coronary Syndrome 03/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2010
1	HIV Infections (HIV Infection) 08/2009
1	Herpesviridae Infections (Herpesvirus Infection) 07/2008
1	Virus Diseases (Viral Diseases) 07/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2005

Drug/Important Bio-Agent (IBA)

12	Anti-Infective Agents (Microbicides)IBA 11/2016 - 02/2006
5	PRO 2000 (PRO-2000)IBA 08/2009 - 06/2004
4	Local Anti-Infective Agents (Antiseptics)IBA 07/2007 - 06/2004
3	Pharmaceutical PreparationsIBA 01/2019 - 07/2007
3	Tenofovir (Viread)FDA Link 01/2019 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 03/2009 - 05/2007
2	Oxygen (Dioxygen)IBA 01/2022 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2009
2	Contraceptive Agents (Contraceptives)IBA 02/2010 - 03/2009
2	cellulose sulfateIBA 08/2009 - 06/2004
2	Nonoxynol (Nonoxynol 9)FDA Link 08/2009 - 01/2009
2	Reverse Transcriptase InhibitorsIBA 07/2008 - 07/2007
1	boldenone undecylenate (Equipoise)IBA 01/2022
1	Metronidazole (Metric)FDA LinkGeneric 12/2021
1	Neutralizing AntibodiesIBA 10/2020
1	CytokinesIBA 10/2020
1	GlucocorticoidsIBA 08/2020
1	InterleukinsIBA 01/2017
1	CarrageenanIBA 11/2016
1	LubricantsIBA 11/2016
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 09/2014
1	Aligeron (AS 2)IBA 07/2012
1	Cytokine Receptors (Cytokine Receptor)IBA 03/2010
1	OsteoprotegerinIBA 03/2010
1	Hormones (Hormone)IBA 02/2010
1	LuciferasesIBA 01/2010
1	Adenine FDA LinkGeneric 08/2009
1	hydroxyethylcelluloseIBA 01/2009
1	GelsIBA 07/2008
1	PolymersIBA 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	DefensinsIBA 12/2006
1	beta-DefensinsIBA 12/2006
1	alpha-DefensinsIBA 12/2006
1	Antimicrobial PeptidesIBA 01/2005
1	Complement System Proteins (Complement)IBA 01/2005
1	Acyclovir (Aciclovir)FDA LinkGeneric 06/2004
1	polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric 06/2004

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2007
1	Artificial Respiration (Mechanical Ventilation) 08/2020
1	Transplantation 01/2019
1	Condoms (Condom) 10/2012
1	Hormonal Contraception 02/2010